Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

Author： Knop F.   Vilsbøll T.   Madsbad S.   Holst J.   Krarup T.  

Publisher： Springer Publishing Company

ISSN： 0012-186X

Source： Diabetologia, Vol.50, Iss.4, 2007-04, pp. : 797-805

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus

By Cypryk Katarzyna   Vilsbøll Tina   Nadel Iwona   Smyczynska Joanna   Holst Jens Juul   Lewinski Andrzej  

Gynecological Endocrinology, Vol. 23, Iss. 1, 2007-01 ,pp. : 58-62

Informa Healthcare

Access to resources Recommend Favorite

Incretin-based Therapies for Type 2 Diabetes Mellitus: Effects on Insulin Resistance

By  

Current Diabetes Reviews, Vol. 9, Iss. 5, 2013-09 ,pp. : 412-417

Bentham Science Publishers

Access to resources Recommend Favorite

Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects

By Meier J.   Deacon C.   Schmidt W.   Holst J.   Nauck M.  

Diabetologia, Vol. 50, Iss. 4, 2007-04 ,pp. : 806-813

Springer Publishing Company

Access to resources Recommend Favorite

Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?

By Schrauwen P.   Hesselink M.  

Diabetologia, Vol. 51, Iss. 9, 2008-09 ,pp. : 1694-1697

Springer Publishing Company

Access to resources Recommend Favorite

Alterations of Glucose Metabolism in Type 2 Diabetes Mellitus. An Overview

By Bonadonna Riccardo C.  

Reviews in Endocrine and Metabolic Disorders, Vol. 5, Iss. 2, 2004-05 ,pp. : 89-97

Springer Publishing Company

Access to resources Recommend Favorite